학술논문
Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
Document Type
Article
Author
McDonald, C.M.; Henricson, E.K.; Marbán, E.; Hendrix, S.; Hogan, N.; Ruckdeschel Smith, R.; Ascheim, D.D.; Rogy, S.; Williams, P.; Marbán, L.; Eagle, M.; Finkel, R.S.; Tian, C.; Taylor, M.D.; Janas, J.; Harmelink, M.M.; Varadhachary, A.S.; Hor, K.N.; Mayer, O.H.; Furlong, P.; Butterfield, R.; Connolly, A.; Muntoni, F.; Joyce, N.C.; Evans, M.; Abedi, M.; Surampudi, P.; Jhawar, S.; Dayan, J.G.; Anthonisen, C.; Goude, E.; Nicorici, A.; Sarwary, O.; Prasad, P.; Baek, J.; Newton, A.; Johnson, H.; Kusmik, K.; Filar, L.; Edmondson, A.; Rybalsky, I.; Chouteau, W.; Giordano, A.F.; Rodriguez, A.; Anderson, K.; Wezel, G.; Vega, M.; Duke, J.; Collado, J.; Civitello, M.; Wells, J.; Pyzik, E.; Rehborg, R.; Brown, M.; Van Eyk, J.; Rogers, R.G.
Source
In: The Lancet . (The Lancet, 12 March 2022, 399(10329):1049-1058)
Subject
Language
English
ISSN
1474547X
01406736
01406736